A. Take her blood pressure twice a day to check for hypertension. Lithium does not typically cause hypertension. Monitoring blood pressure is not a primary concern for patients on lithium.
B. Have her drug blood level checked every month. Regular monitoring of lithium blood levels is crucial to ensure therapeutic levels and avoid toxicity. Lithium has a narrow therapeutic window, and frequent monitoring helps in adjusting the dose to maintain safe and effective levels.
C. Avoid aged cheese and red wine. This advice is relevant for patients taking MAOIs, not lithium. There is no need for patients on lithium to avoid these foods specifically.
D. Examine her skin closely for eruptions. While skin eruptions can be a side effect of some medications, it is not a primary concern for patients on lithium. The focus should be on monitoring for signs of lithium toxicity and other common side effects like tremors, thyroid dysfunction, and renal impairment.

A. Is commonly known as a cold sore: Cold sores are typically caused by herpes simplex type 1 (HSV-1), not type 2.
B. Usually affects the labia in women. While HSV-2 can affect the labia, it is not exclusive to this area and can affect other genital regions in both men and women.
C. Is characterized by a vesicle at the corner of the mouth, lips, or nose. These symptoms are more characteristic of HSV-1.
D. Is often associated with lesions in the genital area. Herpes simplex type 2 (HSV-2) is primarily associated with genital herpes, causing lesions and outbreaks in the genital and anal areas.

A. Overflow incontinence. Overflow incontinence occurs when the bladder does not empty properly, leading to frequent or constant dribbling. It is not typically triggered by physical activities like sneezing.
B. Functional incontinence. Functional incontinence is due to physical or cognitive impairments that prevent a person from reaching the bathroom in time, rather than a physiological issue with the bladder or urethra.
C. Urge incontinence. Urge incontinence involves a sudden, intense urge to urinate followed by involuntary loss of urine. It is not typically triggered by physical activities like sneezing.
D. Stress incontinence. Stress incontinence occurs when there is involuntary leakage of urine during physical activities that increase abdominal pressure, such as sneezing, coughing, or exercising.

A. Dalmane (flurazepam) is a benzodiazepine used to treat insomnia and is not commonly associated with date rape.
B. Xanax (alprazolam) is a benzodiazepine used to treat anxiety and panic disorders but is not commonly associated with date rape.
C. Narcan (naloxone) is an opioid antagonist used to reverse opioid overdoses. It has no sedative properties and is not associated with date rape.
D. Rohypnol (flunitrazepam) is a potent benzodiazepine that has been used illicitly in cases of sexual assault due to its strong sedative and amnesic effects.

A. Meeting patient goals. While meeting patient goals is important, it is the result of care and does not directly build trust or address psychosocial needs on its own.
B. Developing a care plan. Developing a care plan is essential for organizing patient care, but it is a behind-the-scenes activity that the patient may not directly perceive as building trust or addressing psychosocial needs.
C. Implementing nurse orders. Implementing nurse orders is part of routine care delivery but does not specifically build trust or address psychosocial needs.
D. Patient education. Patient education helps build trust by empowering patients with knowledge about their condition and care plan. It encourages patients to have confidence in the care they are receiving and addresses their psychosocial needs by reducing anxiety and uncertainty.

A. Herpes zoster virus usually is permanently disabling to healthy adults. Herpes zoster (shingles) can cause significant pain and discomfort, but it is not typically permanently disabling to healthy adults.
B. The pain experienced by most patients is typically described as "dull and aching." The pain associated with herpes zoster is usually described as sharp, burning, or stabbing rather than dull and aching.
C. There is usually a rash that occurs in the thoracic region. The rash associated with herpes zoster often appears in a dermatomal distribution, commonly in the thoracic region, following a nerve pathway on one side of the body.
D. Analgesics are often prescribed for pain; however, steroids are usually avoided because of the immune system suppression. While analgesics are commonly prescribed for pain management in herpes zoster, steroids may be used in certain cases to reduce inflammation, particularly if there is nerve involvement. The use of steroids should be carefully considered based on the patient’s overall health and immune status.

A. Within 1 to 2 months. While some recovery may be seen within the first 1 to 2 months, it is typically an ongoing process, and significant improvements are often seen over a longer period.
B. Within 2 to 3 weeks. This timeframe is too short for significant recovery of neurologic function. Initial recovery is most rapid in the first few weeks, but continued improvement is expected over months.
C. Within 6 to 9 months. While recovery can continue up to 6 to 9 months or longer, most significant improvements in neurologic function occur within the first 3 to 6 months.
D. Within 3 to 6 months. This is the period during which the most significant recovery of neurologic function typically occurs following a stroke.

A. Every 6 months. Semi-annual screenings may be necessary for certain conditions or if there are ongoing health issues, but generally, an annual check-up is sufficient for preventive health.
B. Every 3 years. This interval is too long for preventive health screenings in older adults, who are at higher risk for various health conditions.
C. Every 2 years. This interval may be appropriate for certain screenings, but annual check-ups are recommended to ensure timely detection and management of health issues.
D. Every year. Annual health screenings are recommended for older adults to monitor for chronic conditions, update vaccinations, and promote overall health.

A. Dermis. The dermis contains connective tissue, blood vessels, and other structures but not melanocytes.
B. Superficial fascia. The superficial fascia, or hypodermis, is primarily composed of fat and connective tissue and does not contain melanocytes.
C. Epidermis. Melanocytes are located in the basal layer of the epidermis, where they produce melanin.
D. Loose connective tissue. Loose connective tissue is found in various parts of the body but does not contain melanocytes responsible for skin pigmentation.

A. Help the patient interact in nonaddictive activities. While engaging in nonaddictive activities is important for long-term recovery, the primary concern during the detoxification period is managing withdrawal symptoms and ensuring safety.
B. Enroll the patient in Alcoholics Anonymous (AA). Enrolling in AA or similar support groups is beneficial for ongoing recovery, but the focus during detoxification should be on managing acute withdrawal symptoms and safety.
C. Keep the patient safe from aspiration and seizure. During detoxification, patients are at risk for serious complications such as seizures and aspiration due to withdrawal symptoms. Ensuring patient safety by monitoring for these conditions is a primary goal.
D. Help the patient gain insight into the addiction. Gaining insight into addiction is important for long-term recovery but is not the immediate priority during the detoxification period, which focuses on managing physical withdrawal symptoms and ensuring patient safety.